Postexposure prophylaxis following HIV exposure.
Kahn
J G
JG
Pinkerton
S D
SD
Paltiel
A D
AD
D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D007348:Insurance, Health; D011050:Policy Making; D011315:Preventive Medicine / Q000191:economics; D014481:United States
D019380:Anti-HIV Agents